War risk premiums briefly eased to around 0.5% of the value of a...
Category:
Intermediaries
Latest
Aon’s president Eric Andersen made sr advisor to CEO Case
The role of president has been assumed by Case. Andersen joined Aon...
PB Fintech stock declines nearly 5 pc
NEW DELHI: Shares of PB Fintech, parent entity of Policybazaar,...
Cybersecurity is top business worry in ‘age of risk’: Marsh & McLennan CEO
“CEOs like to get things done and say it’s finished,” he said. “Cyber is a never-ending phenomenon. It will continue for the rest of all of our careers.”
Climate change and the culture of remote working are the other top risks cited by companies, Glaser said. Climate is less immediate than cybersecurity because it is developing slowly and its impact, through such catastrophic events as larger wildfires and more powerful hurricanes, will increase over the next five years or more.
Willis Towers Watson acquires Acclimatise, to strengthen climate resilience leadership
John Firth, CEO and Co-Founder of Acclimatise, said, “Climate change risk is fast becoming a central part of government, corporate and financial decision making and planning. Meeting growing client demand will require increasingly sophisticated approaches to climate risk assessment and management.”
Insurtech Coherent secures $14mn investment from Cathay Innovation and Franklin Templeton
The new funding from Cathay Innovation and Franklin Templeton provides Coherent with the ability to invest and rapidly expand its operations and capability..Coherent will add technology and actuarial talent to its growing workforce at its current offices in Hong Kong, Singapore, Shanghai and Manila plus hire new teams in Japan, USA and Thailand. The increased reach will also extend its customer portfolio which currently covers large insurers in Hong Kong, Singapore, Indonesia, Mainland China, Japan, the Philippines, Thailand, Brazil and Myanmar.
Oneglobal Broking sets up Singapore operation
Oneglobal’s strategy is to build out its operations in Asia, of which the establishment of a Singapore company is a key element and follows its announcement of the opening of Hong Kong in August this year, with further offices and senior broker hires to follow.
Cinven and Singapore’s GIC to acquire specialist insurance broker Miller
Headquartered in London, it places £2 billion worth of premiums annually.
Founded in 1902, Miller is a leading specialist insurance and (re)insurance broker operating in the UK, Lloyd’s and internationally. It employs more than 640 people through its offices in London, Ipswich, Brussels, Paris, Singapore and Geneva, covering the world’s major insurance hubs.
True North part-exits Policybazaar
The PE fund, however, did not share financial details on the exit like the stake sold or returns made
India Post Payments to sell AIC’s Crop Insurance products
This strategic tie-up will be a win-win for both AIC and IPPB and will ultimately be beneficial mainly to the small and marginal farmers of the country at large.
IBAI votes out its president Sanjay Kedia, elects five new faces as directors
IBAI’s 15-member board of directors, have chosen Sumit Bohra as the new the new president of the association.
After voting out some existing directors who were seeking re-election, the brokers had elected five new faces as directors for three years,.
They are Sundaram Venkatavaradan of Abhivridhi Insurance Brokers. Rashmi Ravi Iyer of Global Insurance Brokers, Sandeep Dadia of Aditya Birla Insurance Brokers, Mohan Sriraman of Paavana Insurance Brokers, Surender Kumar Tonk of Advance Life Insurance Brokers
Asia Pacific health care benefit cost expected to jump by 8.5% in 2021, Willis Towers Watson survey
The 2021 Global Medical Trends Survey, the largest of its kind, found that medical insurers in APAC project health care benefit costs will take a sudden drop in 2020 before rebounding to 8.5% in 2021, up from 6.2% this year and 7.5% in 2019.
Markets including China (9.3%), India (10%), Indonesia (12%), Malaysia (12.5%), New Zealand (20%), Philippines (8.8%), Singapore (8.2%), Thailand (8%) and Vietnam (10.2%) will see an increase in excess of 8% next year.
According to the study, cancer (79%), cardiovascular diseases (76%), and conditions affecting musculoskeletal and connective tissue (42%) are the top three conditions currently affecting medical costs in APAC, with cancer and cardiovascular diseases expected to remain so in the near future.
As globe gallops into vaccine trials, insurers remain unfazed
While more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don’t see anything to be unduly concerned about.
Executives at insurer Allianz and brokers Gallagher and Marsh, among the leading players in clinical trials insurance, told Reuters that premiums had only marginally increased so far in the current pandemic